SE9900398L - Ny användning inom transplantationskirurgi - Google Patents

Ny användning inom transplantationskirurgi

Info

Publication number
SE9900398L
SE9900398L SE9900398A SE9900398A SE9900398L SE 9900398 L SE9900398 L SE 9900398L SE 9900398 A SE9900398 A SE 9900398A SE 9900398 A SE9900398 A SE 9900398A SE 9900398 L SE9900398 L SE 9900398L
Authority
SE
Sweden
Prior art keywords
transplantation
new use
transplant surgery
present
islets
Prior art date
Application number
SE9900398A
Other languages
Unknown language ( )
English (en)
Other versions
SE9900398D0 (sv
SE523817C2 (sv
Inventor
Olle Korsgren
William Bennet
Bo Nilsson
Rolf Larsson
Original Assignee
Corline Systems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corline Systems Ab filed Critical Corline Systems Ab
Priority to SE9900398A priority Critical patent/SE523817C2/sv
Publication of SE9900398D0 publication Critical patent/SE9900398D0/sv
Priority to EP00906843A priority patent/EP1171156B1/en
Priority to US09/890,936 priority patent/US7981873B1/en
Priority to AU28399/00A priority patent/AU769063B2/en
Priority to DE60032346T priority patent/DE60032346T2/de
Priority to JP2000596956A priority patent/JP2003501346A/ja
Priority to AT00906843T priority patent/ATE348149T1/de
Priority to CA2361949A priority patent/CA2361949C/en
Priority to PCT/SE2000/000223 priority patent/WO2000045837A1/en
Publication of SE9900398L publication Critical patent/SE9900398L/sv
Publication of SE523817C2 publication Critical patent/SE523817C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9900398A 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler SE523817C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
PCT/SE2000/000223 WO2000045837A1 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
DE60032346T DE60032346T2 (de) 1999-02-05 2000-02-04 Neue Verwendung in der Transplantationsschirugie
US09/890,936 US7981873B1 (en) 1999-02-05 2000-02-04 Use within transplantation surgery
AU28399/00A AU769063B2 (en) 1999-02-05 2000-02-04 Novel use within transplantation surgery
EP00906843A EP1171156B1 (en) 1999-02-05 2000-02-04 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin
JP2000596956A JP2003501346A (ja) 1999-02-05 2000-02-04 移植手術における新規な使用
AT00906843T ATE348149T1 (de) 1999-02-05 2000-02-04 Isolated islets, comprising insulin producing cells, coated with heparin
CA2361949A CA2361949C (en) 1999-02-05 2000-02-04 Heparin, or heparin conjugate, islets of langerhans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Publications (3)

Publication Number Publication Date
SE9900398D0 SE9900398D0 (sv) 1999-02-05
SE9900398L true SE9900398L (sv) 2000-08-06
SE523817C2 SE523817C2 (sv) 2004-05-18

Family

ID=20414376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900398A SE523817C2 (sv) 1999-02-05 1999-02-05 Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler

Country Status (9)

Country Link
US (1) US7981873B1 (sv)
EP (1) EP1171156B1 (sv)
JP (1) JP2003501346A (sv)
AT (1) ATE348149T1 (sv)
AU (1) AU769063B2 (sv)
CA (1) CA2361949C (sv)
DE (1) DE60032346T2 (sv)
SE (1) SE523817C2 (sv)
WO (1) WO2000045837A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200198D0 (sv) 2002-01-23 2002-01-23 Astrazeneca Ab New use
DK1605965T3 (da) * 2003-03-26 2013-04-15 Evotec Internat Gmbh Anvendelse af saposin-beslægtede proteiner til forebyggelse og behandling af obesitet, diabetes og/eller metabolisk syndrom
JP5271705B2 (ja) * 2005-07-01 2013-08-21 コーライン システムズ アーベー 生体組織のヘパリンコーティング
SE530716C2 (sv) 2006-10-06 2008-08-19 Corline Systems Ab Molekylärt aggregat på ett substrat
EP2550004A4 (en) * 2010-03-12 2014-07-02 Univ Australian SUBSTITUTE THERAPY WITH HEPARAN SULFATE
ES2926906T3 (es) 2011-12-22 2022-10-31 Corline Biomedical Ab Medios y método para tratar vasos sanguíneos
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135916A (en) 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
AU654116B2 (en) * 1989-10-12 1994-10-27 Imutran Limited Modified biological material
SE470006B (sv) 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
AU3124793A (en) * 1991-10-29 1993-06-07 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
ES2150945T3 (es) * 1992-05-21 2000-12-16 Diatide Inc Peptidos marcados con tecnecio-99m para obtencion de imagenes de trombos.
WO1997011607A1 (en) 1995-09-27 1997-04-03 Emory University Method of inhibiting immune system destruction of transplanted viable cells
DE19623440A1 (de) * 1996-06-12 1997-12-18 Wagner Karl Heinz Dr Med Immobilisiertes organisches Material mit definiertem Wirkstoff-Release
US6423316B1 (en) * 1997-03-26 2002-07-23 Imperial College Innovative Limited Anticoagulant fusion protein anchored to cell membrane

Also Published As

Publication number Publication date
CA2361949C (en) 2010-08-03
DE60032346D1 (en) 2007-01-25
JP2003501346A (ja) 2003-01-14
WO2000045837A1 (en) 2000-08-10
EP1171156B1 (en) 2006-12-13
ATE348149T1 (de) 2007-01-15
US7981873B1 (en) 2011-07-19
AU2839900A (en) 2000-08-25
SE9900398D0 (sv) 1999-02-05
EP1171156A1 (en) 2002-01-16
AU769063B2 (en) 2004-01-15
CA2361949A1 (en) 2000-08-10
SE523817C2 (sv) 2004-05-18
DE60032346T2 (de) 2007-07-19

Similar Documents

Publication Publication Date Title
Liang et al. Lipid rescue of massive verapamil overdose: a case report
MX2010001784A (es) Activadores novedosos de la glucocinasa.
CN105979975A (zh) 医疗敷料
EP1803710A4 (en) CONDENSED PYRIMIDINE DERIVATIVE CONTAINING NON-AROMATIC CYCLE
EA200970726A1 (ru) Твердый препарат, содержащий алоглиптин и пиоглитазон
EP1803721A4 (en) INNOVATIVE GLUCITOL DERIVATIVE, PRECURSOR OF THE MEDICINAL PRODUCT AND SALT THEREOF, AND A THERAPEUTIC AGENT FOR DIABETES CONTAINING THE SAME
WO2005103687A3 (en) System and method for providing optimal concentrations for medication infusions
SE9900398L (sv) Ny användning inom transplantationskirurgi
CN1387439A (zh) 糖尿肾病和微蛋白尿的治疗方法
RU2009110273A (ru) Способ уменьшения повреждения нервных клеток
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
JPS61194020A (ja) 網膜症治療剤
BR0316666A (pt) Novo uso de sulfato de dextrano
BR0306798A (pt) Uso de melagatran ou de um derivado farmaceuticamente aceitável deste, métodos de tratamento de diabetes mellitus tipo i, de transplante de células de enxertamento de ilhotas de langerhans, para melhorar a independência de insulina em pacientes com diabetes mellitus tipo i, e de tratamento de reação inflamatória mediada pelo sangue instantânea, formulação farmacêutica para uso no tratamento de diabetes mellitus tipo i, kit de partes, e, método de fabricação de um kit de partes.
DE60111637D1 (de) Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
CN101618027B (zh) 醋氯芬酸双层渗透泵控释片及其制备方法
KR20080061431A (ko) 에이디피-라이보실 사이클레이즈 억제제를 이용한 고혈압 및 당뇨병성 신증의 치료제
TR200200250T2 (tr) Glukoz alma agonistleri olarak yeni naftilsülfonik asitler, ilgili bileşikler
CN107970238A (zh) 苦参碱在制备抑制神经炎症药物中的应用
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
Wallenborn et al. Intensive care in a patient with toxic epidermal necrolysis
CN112209834B (zh) 一种有机亚硝酸根供体及其制备方法与医药用途
Xie et al. Biomaterial-mediated strategies for accurate and convenient diagnosis, and effective treatment of diabetes: advantages, current progress and future perspectives
CN2870885Y (zh) 长效降血压埋植棒

Legal Events

Date Code Title Description
NUG Patent has lapsed